Kei Pharma Co., Ltd.
Basic information
- Head office
- Tri-Seven Roppongi 6F, 7-7-7 Roppongi, Minato-ku, Tokyo 106-0032
- Chief executive
- Hiroaki Fukushima
- Capital
- 100,000,000 JPY
- Employees (non-consolidated)
- 17 people
- Employees (consolidated)
- Start date
- 2016-11-01
- End date
Websites
Business
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
| Keio University | ||||||||
| 湘南ヘルスイノベーションパーク | ||||||||
|
|
||||||||
| 星薬科大学 | ||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
| Masato Co., Ltd. | ||||||||
| 株式会社凛研究所 | ||||||||
|
|
||||||||
|
|
||||||||
|
|
Network
History
Addressing unmet medical needs such as neurodegenerative diseases and spinal cord injuries is a societal challenge, and the rapid development of effective drugs and therapies is required.![]()
Established Kei Pharma Co., Ltd. in Minato-ku, Tokyo, with the purpose of researching, developing, manufacturing, and selling pharmaceutical and regenerative medicine products.![]()
Founded Kei Pharma Co., Ltd. together with Dr. Eiichi Okano of Keio University School of Medicine and Dr. Masaya Nakamura of the Department of Orthopedic Surgery.![]()
Entered into a joint research agreement with Keio University with the aim of developing pharmaceutical and regenerative medicine products utilizing iPS cells.![]()
Entered into a joint research agreement with Keio University for clinical trials of regenerative medicine using iPS cell-derived neural progenitor cells for subacute spinal cord injury.![]()
Established the "Kei Pharma-Keio Spinal Cord Regeneration Lab" in the Comprehensive Medical Science Research Building on Keio University's Shinano-cho campus.![]()
Signed a licensing agreement with Alfressa Pharma Inc. regarding the derivation of KP2011, a candidate drug for ALS in Japan.![]()
Entered into a joint research agreement with the Kitasato Institute for clinical trials of hearing loss therapeutics.![]()
News
Our company's iPS drug discovery business and regenerative medicine business featured in Daily Pharmaceutical News
K Pharma Co., Ltd.'s efforts in drug discovery and regenerative medicine utilizing iPS cells, as well as future strategies, were introduced in the Daily Pharmaceutical News dated December 26, 2025.
Public records
National Tax Agency basic information9010401128001
- Trade name
- 株式会社ケイファーマ
- Trade name (kana)
- ケイファーマ
- Name in English
- Corporation type
- 301
- Address
- 〒106-0032 東京都港区六本木7丁目7番7号
- Postal code
- 1060032
- Prefecture code
- 13
- City code
- 103
- Address outside Japan
- Prefecture in English
- City in English
- Address outside Japan in English
- Corporate number assignment date
- 2016-11-08
- Update date
- 2018-05-09
- Change date
- 2016-11-08
- Registry closure date
- Reason for registry closure
- Successor corporate number
- Details of the change
- Latest record
- 1
- Excluded from search
- 0
- Processing type
- 01
- Correction type
- 1
- Trade name image ID
- Address image ID
- Sequence number
- 2493140
METI gBizINFO9010401128001
- Corporate number
- 9010401128001
- Trade name
- 株式会社ケイファーマ
- Trade name (kana)
- ケイファーマ
- Trade name (alphabet)
- Registry closure date
- Reason for registry closure
- Registered address
- 東京都港区六本木7丁目7番7号
- Postal code
- 1060032
- Prefecture
- 東京都
- Prefecture code
- 13
- City or district
- 港区
- City code
- 103
- Street address
- 六本木7丁目7番7号
- Organisation type
- 301
- Processing type
- 01
- Correction type
- 1
- Status
- Representative
- 代表取締役社長 福島 弘明
- Capital
- 10175000
- Employees
- 20
- Employees (male)
- Employees (female)
- Business summary
- Website URL
- Year founded
- Business category
- Date established
- Unified government qualification - grade
- Unified government qualification - business items
- Update date
- 2018-05-09
- Key information
- 9010401128001